China–United States Research Collaborations in Antimicrobial Resistance

Duin, David van; Gu, Peidi; Dong, Jianyu; Paff, Melanie; Arias, Rebekka M.; Evans, Beth; Yu, Yunsong; Li, Lanjuan; Zhang, Fujie; Liu, Zhengyin; Cao, Bin; Fowler, Vance G.; Wang, Minggui

doi:10.1093/cid/ciy694

Cited by 3 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also, a recent study demonstrated that China leads in terms of the numbers of worldwide reports made on mcr genes (4,917 strains identified in mcr-1 gene, and 274 strains identified in a variant mcr genes) (Elbediwi et al, 2019). The fact that more Chinese students and academics are collaborating with researchers from Western developed countries also contributes to China's growth (Akanwa, 2015;Van Duin et al, 2018). As has been pointed out by other studies (Ramos-Rincón et al, 2019;González-Alcaide et al, 2020), China's emergence in scientific production is remarkable and has advanced by leaps and bounds in recent years (Bornmann et al, 2015), including the area of pharmacology/pharmacy (Ding et al, 2013).…”

Section: Discussionmentioning

confidence: 99%

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

Quincho-Lopez

Pacheco‐Mendoza

2021

Front. Pharmacol.

View full text Add to dashboard Cite

Background: Antimicrobial resistance is a serious public health problem that has become a global threat. Special attention should be given to polymyxins (polymyxin B and colistin) which, since their reintroduction into clinical practice, are considered “last resort” drugs. The objective of this study is to perform a bibliometric analysis of scientific research on polymyxin resistance.Methods: Scopus was used to retrieve documents relevant to polymyxin resistance from 2010 to 2019. Data was exported to Microsoft Excel for table presentation. SciVal was used for volume and citation analysis as well as collaboration patterns. Also, we extracted data regarding the top documents, authors, countries, institutions, and the metrics of journals. VantagePoint and VOSviewer were used for geographical distribution of worldwide research and keyword co-occurrence analysis, respectively.Results: A total of 1,409 documents were retrieved. The retrieved documents received 25.0 citations per document. Articles (73.88%) and letters (18.09%) were the most frequent types of documents. During 2010–2019, there was a significant growth in publications (p-value < 0.001). The received citations were 35,209 with a peak in 2016 (11,250 citations). China and the United States led the scientific production with 299 (21.2%) and 238 (16.9%) publications, respectively. Little or no contribution came from central Asia, Sub-Saharan Africa, and Latin America. Chinese institutions have caused the greatest impact, with University of Zhejiang (China) being the most prolific institution on the subject (88 documents). In terms of the most productive journals, Antimicrobial Agents and Chemotherapy ranked first with 196 (13.9%) documents. Most of the documents were published in quartile one journals and only had national collaboration (43.2%). Analysis of keyword co-occurrence revealed that research on polymyxin resistance during the last decade has focused on its relationship with public health, pharmacology, and genetics.Conclusion: The number of documents on polymyxin resistance has increased significantly in the recent years, with a steep growth from 2016 onwards. China and the United States led the scientific production. Most of the documents were published in high-quality journals. Greater joint efforts and more contribution from central Asia, Sub-Saharan Africa, and Latin America are still needed to tackle this global problem.

show abstract

Section: Discussionmentioning

confidence: 99%

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

Quincho-Lopez

Pacheco‐Mendoza

2021

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

Cross,

Greenwood-Quaintance,

Souli

et al. 2023

Clinical Infectious Diseases

View full text Add to dashboard Cite

Developing and implementing the scientific agenda of the Antibacterial Resistance Leadership Group (ARLG) by soliciting input and proposals, transforming concepts into clinical trials, conducting those trials, and translating trial data analyses into actionable information for infectious disease clinical practice is the collective role of the Scientific Leadership Center, Clinical Operations Center, Statistical and Data Management Center, and Laboratory Center of the ARLG. These activities include shepherding concept proposal applications through peer review; identifying, qualifying, training, and overseeing clinical trials sites; recommending, developing, performing, and evaluating laboratory assays in support of clinical trials; and designing and performing data collection and statistical analyses. This article describes key components involved in realizing the ARLG scientific agenda through the activities of the ARLG centers.

show abstract

Leveraging collaborative research networks against antimicrobial resistance in Asia

He,

Shrestha,

Henry

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundAntimicrobial resistance (AMR) is a global health security threat requiring research collaboration globally and regionally. Despite repeated calls for international research collaboration in Asia, literature analyzing the nature of collaborative AMR research in Asia has been sparse. This study aims to describe the characteristics of the AMR research network in Asia and investigate the factors influencing collaborative tie formation between organizations.MethodsWe carried out a mixed-methods study by combining social network analysis (SNA) and in-depth interviews. SNA was first conducted on primary data to describe the characteristics of the AMR research network in Asia. Exponential random graph models (ERGMs) were then used to examine the influence of factors such as organization type, country affluence levels, regional proximity and One Health research on collaborative tie formation among organizations. In-depth interviews were conducted with network participants to provide contextual insights to the quantitative data.ResultsThe results reveal that the research network exhibits a core-periphery structure, where a minority of organizations have a significantly higher number of collaborations with others. The most influential organizations in the network are academic institutions from high-income countries within and outside Asia. The ERGM results demonstrate that organizations prefer to collaborate with others of similar organization types, country-based affluence levels and One Health domains of focus, but also with others across different World Health Organization regions. The qualitative analysis identified three main themes: the challenges that impede collaboration, the central role of academic institutions, and the nature of collaborations across One Health domains, giving rise to important empirical milestones in understanding AMR research in Asia.ConclusionWe thus recommend leveraging academic institutions as “integrators” to bridge differences, increasing funds channelled towards research capacity building to alleviate structural barriers to collaboration, streamlining collaborative mechanisms to overcome cumbersome administrative hurdles, and increasing efforts to establish trust between all organizations.

show abstract

China–United States Research Collaborations in Antimicrobial Resistance

Cited by 3 publications

References 22 publications

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)

Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group

Leveraging collaborative research networks against antimicrobial resistance in Asia

Contact Info

Product

Resources

About